Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Hydroxychloroquine fights malaria and calms lupus through the same basic trick: making acidic cellular compartments less acidic.
Doxycycline is the preferred antibiotic for serious Bartonella infections, though most cat-scratch disease resolves without any drug at all.
A single oral dose of azithromycin is replacing painful penicillin shots in the global campaign against yaws. Here is what the evidence actually shows.
In 2011 mebendazole moved from chewable to film-coated tablets. Here is what changed pharmacologically, and what the evidence actually shows about treatment failures.
Low-dose doxycycline treats rosacea and gum disease through an anti-inflammatory pathway distinct from its antibiotic action—a genuine pharmacological discovery worth understanding.
Doxycycline prevents malaria by stopping the parasite before it can multiply—but only if taken on schedule. Here is the biology behind the regimen and the timing rules.
Topical ivermectin kills lice but not their eggs—yet clinical trials show it still breaks the infestation cycle. Here's the evidence and how it compares with permethrin.
Crusted (Norwegian) scabies in immunocompromised patients needs several ivermectin doses over weeks, not one. Here is the biology and evidence behind why.
How a bark-derived remedy from the Andes led to two related drugs, and why parasite resistance—not hydroxychloroquine—became malaria's real challenge.